Grupo Cibest S.A.
CIBNYSEFinancial Services● Active
$71.80
+$0.92(+1.30%)
Market Cap$17.0B
P/E Ratio—
52W High$86.31
52W Low$41.42
Grupo Cibest S.A.（CIB）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CIB · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $3.942T | $6.366T | $6.215T | $6.996T | $4.208T |
| Depreciation & Amort. | $1.056T | $1.011T | $1.083T | $0.949T | $0.855T |
| Stock-Based Comp. | $0.000T | $0.000T | $0.000T | $0.000T | $0.000T |
| Change in Working Capital | ($0.785T) | ($14.177T) | $4.816T | ($5.359T) | ($2.460T) |
| Net Cash from Operations | $12.259T | $0.436T | $19.153T | $6.339T | $6.603T |
| Investing Activities | |||||
| Capital Expenditure | ($2.244T) | ($2.042T) | ($2.412T) | ($3.539T) | ($2.186T) |
| Purchases of Investments | ($2.425T) | ($2.698T) | ($11.590T) | ($11.733T) | ($12.618T) |
| Sales of Investments | $2.232T | $3.970T | $14.009T | $11.256T | $13.753T |
| Net Cash from Investing | ($2.216T) | ($0.559T) | ($0.160T) | ($4.655T) | ($0.650T) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.431T) | $0.000T | $0.000T | $0.000T | $0.000T |
| Dividends Paid | ($5.197T) | ($3.399T) | ($3.298T) | ($2.311T) | ($0.467T) |
| Debt Issued / Repaid | ($2.635T) | ($6.377T) | ($2.396T) | $3.781T | ($4.886T) |
| Net Cash from Financing | ($8.247T) | ($9.244T) | ($5.431T) | $0.853T | ($6.810T) |
| Free Cash Flow | |||||
| Free Cash Flow | $10.015T | ($1.606T) | $16.741T | $2.801T | $4.417T |
| FCF Margin %(computed) | 23.33% | -3.74% | 37.06% | 8.57% | 20.37% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · COP · T
深入了解Grupo Cibest S.A.
关于Grupo Cibest S.A.（CIB）现金流量表
Grupo Cibest S.A. 2025财年经营活动现金流$12258.94B，自由现金流$10014.72B（FCF利润率23.33%），资本支出($2244.22B)。
常见问题
CIB · 4 问Grupo Cibest S.A. 2025财年自由现金流$10014.72B，同比up723.5%。
CIB free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10